-
Je něco špatně v tomto záznamu ?
Specification of Sprouty2 functions in osteogenesis in in vivo context
B. Vesela, E. Svandova, M. Hovorakova, R. Peterkova, A. Kratochvilova, M. Pasovska, A. Ramesova, H. Lesot, E. Matalova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2004 do Před 1 rokem
PubMed Central
od 2004
Europe PubMed Central
od 2004 do Před 1 rokem
ROAD: Directory of Open Access Scholarly Resources
od 2004
- MeSH
- buněčná diferenciace MeSH
- cytoplazma metabolismus MeSH
- faktor 1 indukovatelný hypoxií - podjednotka alfa metabolismus MeSH
- ligand RANK metabolismus MeSH
- membránové proteiny genetika fyziologie MeSH
- myši inbrední ICR MeSH
- myši knockoutované MeSH
- myši MeSH
- osteoblasty cytologie metabolismus MeSH
- osteocyty cytologie metabolismus MeSH
- osteogeneze * MeSH
- osteoklasty cytologie metabolismus MeSH
- osteoprotegerin metabolismus MeSH
- proliferace buněk MeSH
- protein-serin-threoninkinasy genetika fyziologie MeSH
- vývoj kostí MeSH
- vývojová regulace genové exprese * MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Sprouty proteins are modulators of the MAPK/ERK pathway. Amongst these, Sprouty2 (SPRY2) has been investigated as a possible factor that takes part in the initial phases of osteogenesis. However, the in vivo context has not yet been investigated and the underlying mechanisms taking place in vitro remain unknown. Therefore, in this study, the impact of Spry2 deficiency was examined in the developing tibias of Spry2 deficient (-/-) mouse. The investigation was performed when the osteogenic zone became clearly visible and when all three basic bone cells types were present. The main markers of osteoblasts, osteocytes and osteoclasts were evaluated by immunohistochemistry and RT-PCR. RT-PCR showed that the expression of Sost was 3.5 times higher in Spry2-/- than in the wild-type bone, which pointed to a still unknown mechanism of action of SPRY2 on the differentiation of osteocytes. The up-regulation of Sost was independent of Hif-1α expression and could not be related to its positive regulator, Runx2, since none of these factors showed an increased expression in the bone of Spry2-/- mice. Regarding the RANK/RANKL/OPG pathway, the Spry2-/- showed an increased expression of Rank, but no significant change in the expression of Rankl and Opg. Thanks to these results, the impact of Spry2 deletion is shown for the first time in the developing bone as a complex organ including, particularly, an effect on osteoblasts (Runx2) and osteocytes (Sost). This might explain the previously reported decrease in bone formation in postnatal Spry2-/- mice.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20022965
- 003
- CZ-PrNML
- 005
- 20230510130052.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/15476278.2019.1656995 $2 doi
- 035 __
- $a (PubMed)31480885
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vesela, Barbora $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic.
- 245 10
- $a Specification of Sprouty2 functions in osteogenesis in in vivo context / $c B. Vesela, E. Svandova, M. Hovorakova, R. Peterkova, A. Kratochvilova, M. Pasovska, A. Ramesova, H. Lesot, E. Matalova,
- 520 9_
- $a Sprouty proteins are modulators of the MAPK/ERK pathway. Amongst these, Sprouty2 (SPRY2) has been investigated as a possible factor that takes part in the initial phases of osteogenesis. However, the in vivo context has not yet been investigated and the underlying mechanisms taking place in vitro remain unknown. Therefore, in this study, the impact of Spry2 deficiency was examined in the developing tibias of Spry2 deficient (-/-) mouse. The investigation was performed when the osteogenic zone became clearly visible and when all three basic bone cells types were present. The main markers of osteoblasts, osteocytes and osteoclasts were evaluated by immunohistochemistry and RT-PCR. RT-PCR showed that the expression of Sost was 3.5 times higher in Spry2-/- than in the wild-type bone, which pointed to a still unknown mechanism of action of SPRY2 on the differentiation of osteocytes. The up-regulation of Sost was independent of Hif-1α expression and could not be related to its positive regulator, Runx2, since none of these factors showed an increased expression in the bone of Spry2-/- mice. Regarding the RANK/RANKL/OPG pathway, the Spry2-/- showed an increased expression of Rank, but no significant change in the expression of Rankl and Opg. Thanks to these results, the impact of Spry2 deletion is shown for the first time in the developing bone as a complex organ including, particularly, an effect on osteoblasts (Runx2) and osteocytes (Sost). This might explain the previously reported decrease in bone formation in postnatal Spry2-/- mice.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vývoj kostí $7 D001846
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a cytoplazma $x metabolismus $7 D003593
- 650 12
- $a vývojová regulace genové exprese $7 D018507
- 650 _2
- $a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
- 650 _2
- $a membránové proteiny $x genetika $x fyziologie $7 D008565
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední ICR $7 D008813
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a osteoblasty $x cytologie $x metabolismus $7 D010006
- 650 _2
- $a osteoklasty $x cytologie $x metabolismus $7 D010010
- 650 _2
- $a osteocyty $x cytologie $x metabolismus $7 D010011
- 650 12
- $a osteogeneze $7 D010012
- 650 _2
- $a osteoprotegerin $x metabolismus $7 D053244
- 650 _2
- $a protein-serin-threoninkinasy $x genetika $x fyziologie $7 D017346
- 650 _2
- $a ligand RANK $x metabolismus $7 D053245
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Svandova, Eva $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic.
- 700 1_
- $a Hovorakova, Maria $u Department of Developmental Biology, Institute of Experimental Medicine, Czech Academy of Sciences , Prague , Czech Republic.
- 700 1_
- $a Peterkova, Renata $u Department of Histology and Embryology, Third Faculty of Medicine, Charles University , Prague , Czech Republic.
- 700 1_
- $a Kratochvílová, Adéla $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic. $7 xx0301396
- 700 1_
- $a Pasovska, Martina $u Department of Developmental Biology, Institute of Experimental Medicine, Czech Academy of Sciences , Prague , Czech Republic. Department of Anthropology and Human Genetics, Faculty of Science, Charles University , Prague , Czech Republic.
- 700 1_
- $a Ramesova, Alice $u Department of Physiology, University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic.
- 700 1_
- $a Lesot, Herve $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic.
- 700 1_
- $a Matalova, Eva $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic. Department of Physiology, University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic.
- 773 0_
- $w MED00186379 $t Organogenesis $x 1555-8592 $g Roč. 15, č. 4 (2019), s. 111-119
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31480885 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20230510130047 $b ABA008
- 999 __
- $a ok $b bmc $g 1595284 $s 1113641
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 15 $c 4 $d 111-119 $e 20190904 $i 1555-8592 $m Organogenesis $n Organogenesis $x MED00186379
- LZP __
- $a Pubmed-20201125